GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » Other Current Assets

BTAX (Biostax) Other Current Assets : $0.00 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Biostax Other Current Assets?

Biostax's other current assets for the quarter that ended in Sep. 2024 was $0.00 Mil.


Biostax Other Current Assets Historical Data

The historical data trend for Biostax's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostax Other Current Assets Chart

Biostax Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biostax Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biostax Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Biostax Other Current Assets Related Terms

Thank you for viewing the detailed overview of Biostax's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostax Business Description

Traded in Other Exchanges
N/A
Address
2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Executives
Glen A Farmer officer: Chief Financial Officer 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky director, 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson 10 percent owner, officer: COO and ICEO and IP 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley other: Member of 10% owner group 410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd other: Member of 10% owner group 1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp 10 percent owner, other: Member of 10% owner group 100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi other: Member of 10% owner group 2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes other: Member of 10% owner group 9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth other: Member of 10% owner group 9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz other: Member of 10% owner group 100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd other: Member of 10% owner group 20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko other: Member of 10% owner group 515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc other: Member of 10% owner group 2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey other: Member of 10% owner group 401 FIRST STREET, LOS ALTOS CA 94022